Aralez Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Aralez Pharma (ARLZ) Misses Q2 EPS by 5c
August 9, 2016 8:05 AM EDTAralez Pharma (NASDAQ: ARLZ) reported Q2 EPS of ($0.27), $0.05 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.93 million.
For earnings history and earnings-related data on Aralez Pharma (ARLZ) click here.
... More